medtronic CoreValve

In a research report released 4/5/2010, Credit Suisse is raising their target price to $112 from $105, in Edwards Lifesciences Corp. (NYSE: EW), and maintaining their Outperform rating, to reflect a favorable jury verdict regarding EW's transcatheter valve patent. The Jury found that Medtronic...